Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed May 15, 2015 · 10-Q · 45 days after period end · 0001144204-15-031499
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$454.25K | -$66.87K | -$337.67K | -$3.10M |
| EPS Diluted | $0.00 | $0.00 | $0.00 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end
